Nitazoxanide for Treatment of Cryptosporidium in Children
Status:
NOT_YET_RECRUITING
Trial end date:
2030-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if nitazoxanide (NTZ) can treat Cryptosporidium infection in children age 6-12 months. The main questions it aims to answer are:
* Does NTZ treatment of diarrheal Cryptosporidium infection lower the number of days of diarrhea?
* Does NTZ treatment of diarrheal and non-diarrheal Cryptosporidium infection lower the number of days that parasites can be found in the stool?
Researchers will compare NTZ to a placebo (a look-alike substance that contains no drug) to see if NTZ works to treat Cryptosporidium.
Participants will:
* Take NTZ or placebo for 3 days
* Receive regular visits from field research assistants
* Provide blood and urine samples
Phase:
PHASE3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)